Fenwick Represents Tempus Ex Machina in Acquisition of Biocore to form Infinite Athlete

Fenwick represented Tempus Ex Machina, a developer of a real-time three-dimensional tracking technology, in its acquisition of Biocore, a biomechanics engineering firm. The combined company will be known as Infinite Athlete, with Charlie Ebersol of Tempus Ex serving as Infinite Athlete’s CEO.

Tempus Ex’s acquisition of Biocore will contribute to the technology infrastructure needed to facilitate the development of applications that can use Tempus Ex’s video and data feed platform, FusionFeed API. Tempus Ex is working with the National Football League (NFL) to provide multi-angle video access to enhance social media experiences for the NFL’s sponsors. Tempus Ex is also working with English Premier League club Chelsea FC to leverage its Match View X technology to provide bespoke viewing experiences for fans and the Pac-12 Conference to provide video technology tools to identify athlete injuries. More information can be obtained from the news announcement in the Sports Business Journal.

The Fenwick transaction team included corporate partners Dawn Belt, Scott Behar and Jordan Roberts and associates Matt McCabe, Jordan Beals, Jared Leung, Terence Desouza and law clerk Omar Rifai; technology transactions partners Jonathan Millard and Joseph Schenck and associates Peter Hart, Phillip Yin and Alberto Tohme; executive compensation and employee benefits partner Nancy Chen, counsel Jane Piehler and associates Jonathan Stephenson and Elizabeth Fu; privacy and cybersecurity associate Alyona Eidinger; tax partner Mike Knobler and associate Daphny Lazarus; and patent associate Fredrick Tsang.